For instance, radiotracers for imaging PD-1 (89Zr-Nivolumab) and PD-L1 (18F-BMS-986192) expression in NSCLC patients prior to treatment with nivolumab have been developed [54]. Here, CD274 is linked to non-small cell lung carcinoma.